Global Newcastle Disease Vaccine Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 117
Inquire Before Buying

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.

Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

The global Newcastle Disease Vaccine market is valued at 296.7 million US$ in 2020 is expected to reach 378.5 million US$ by the end of 2026, growing at a CAGR of 3.5% during 2021-2026.

This report focuses on Newcastle Disease Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Newcastle Disease Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Newcastle Disease Vaccine market is segmented into

- Live Vaccines

- Killed Vaccines

Segment by Application

- Chicken

- Duck & Goose

- Other

Global Newcastle Disease Vaccine Market: Regional Analysis

The Newcastle Disease Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Newcastle Disease Vaccine market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Newcastle Disease Vaccine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Newcastle Disease Vaccine market include:

- Merial

- CEVA

- QYH Biotech

- Ringpu Biology

- Yebio

- Harbin Veterinary Research Institute

- Merck Animal Health

- DHN

- Zoetis

- ChengDu Tecbond

- Elanco (Lohmann)

- FATRO

- CAVAC

- Vaksindo

Global Newcastle Disease Vaccine Market Research Report 2020

Table of Contents
1 Newcastle Disease Vaccine Market Overview
1.1 Product Overview and Scope of Newcastle Disease Vaccine
1.2 Newcastle Disease Vaccine Segment by Type
1.2.1 Global Newcastle Disease Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Segment by Application
1.3.1 Newcastle Disease Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease Vaccine Revenue 2015-2026
1.4.2 Global Newcastle Disease Vaccine Sales 2015-2026
1.4.3 Newcastle Disease Vaccine Market Size by Region: 2020 Versus 2026
2 Global Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Newcastle Disease Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Newcastle Disease Vaccine Market Competitive Situation and Trends
2.5.1 Newcastle Disease Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Newcastle Disease Vaccine Players (Opinion Leaders)
3 Newcastle Disease Vaccine Retrospective Market Scenario by Region
3.1 Global Newcastle Disease Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Newcastle Disease Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Newcastle Disease Vaccine Market Facts & Figures by Country
3.3.1 North America Newcastle Disease Vaccine Sales by Country
3.3.2 North America Newcastle Disease Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
3.4.1 Europe Newcastle Disease Vaccine Sales by Country
3.4.2 Europe Newcastle Disease Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Newcastle Disease Vaccine Sales by Region
3.5.2 Asia Pacific Newcastle Disease Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
3.6.1 Latin America Newcastle Disease Vaccine Sales by Country
3.6.2 Latin America Newcastle Disease Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country
3.7.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Newcastle Disease Vaccine Historic Market Analysis by Type
4.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Newcastle Disease Vaccine Price Market Share by Type (2015-2020)
4.4 Global Newcastle Disease Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Newcastle Disease Vaccine Historic Market Analysis by Application
5.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Newcastle Disease Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Newcastle Disease Vaccine Business
6.1 Merial
6.1.1 Corporation Information
6.1.2 Merial Description, Business Overview and Total Revenue
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merial Products Offered
6.1.5 Merial Recent Development
6.2 CEVA
6.2.1 CEVA Newcastle Disease Vaccine Production Sites and Area Served
6.2.2 CEVA Description, Business Overview and Total Revenue
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CEVA Products Offered
6.2.5 CEVA Recent Development
6.3 QYH Biotech
6.3.1 QYH Biotech Newcastle Disease Vaccine Production Sites and Area Served
6.3.2 QYH Biotech Description, Business Overview and Total Revenue
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 QYH Biotech Products Offered
6.3.5 QYH Biotech Recent Development
6.4 Ringpu Biology
6.4.1 Ringpu Biology Newcastle Disease Vaccine Production Sites and Area Served
6.4.2 Ringpu Biology Description, Business Overview and Total Revenue
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ringpu Biology Products Offered
6.4.5 Ringpu Biology Recent Development
6.5 Yebio
6.5.1 Yebio Newcastle Disease Vaccine Production Sites and Area Served
6.5.2 Yebio Description, Business Overview and Total Revenue
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Yebio Products Offered
6.5.5 Yebio Recent Development
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Newcastle Disease Vaccine Production Sites and Area Served
6.6.2 Harbin Veterinary Research Institute Description, Business Overview and Total Revenue
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Harbin Veterinary Research Institute Products Offered
6.6.5 Harbin Veterinary Research Institute Recent Development
6.7 Merck Animal Health
6.6.1 Merck Animal Health Newcastle Disease Vaccine Production Sites and Area Served
6.6.2 Merck Animal Health Description, Business Overview and Total Revenue
6.6.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Animal Health Products Offered
6.7.5 Merck Animal Health Recent Development
6.8 DHN
6.8.1 DHN Newcastle Disease Vaccine Production Sites and Area Served
6.8.2 DHN Description, Business Overview and Total Revenue
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 DHN Products Offered
6.8.5 DHN Recent Development
6.9 Zoetis
6.9.1 Zoetis Newcastle Disease Vaccine Production Sites and Area Served
6.9.2 Zoetis Description, Business Overview and Total Revenue
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Zoetis Products Offered
6.9.5 Zoetis Recent Development
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Newcastle Disease Vaccine Production Sites and Area Served
6.10.2 ChengDu Tecbond Description, Business Overview and Total Revenue
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 ChengDu Tecbond Products Offered
6.10.5 ChengDu Tecbond Recent Development
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Newcastle Disease Vaccine Production Sites and Area Served
6.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Description, Business Overview and Total Revenue
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Elanco (Lohmann) Products Offered
6.11.5 Elanco (Lohmann) Recent Development
6.12 FATRO
6.12.1 FATRO Newcastle Disease Vaccine Production Sites and Area Served
6.12.2 FATRO Newcastle Disease Vaccine Description, Business Overview and Total Revenue
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 FATRO Products Offered
6.12.5 FATRO Recent Development
6.13 CAVAC
6.13.1 CAVAC Newcastle Disease Vaccine Production Sites and Area Served
6.13.2 CAVAC Newcastle Disease Vaccine Description, Business Overview and Total Revenue
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 CAVAC Products Offered
6.13.5 CAVAC Recent Development
6.14 Vaksindo
6.14.1 Vaksindo Newcastle Disease Vaccine Production Sites and Area Served
6.14.2 Vaksindo Newcastle Disease Vaccine Description, Business Overview and Total Revenue
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Vaksindo Products Offered
6.14.5 Vaksindo Recent Development
7 Newcastle Disease Vaccine Manufacturing Cost Analysis
7.1 Newcastle Disease Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
7.4 Newcastle Disease Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Newcastle Disease Vaccine Distributors List
8.3 Newcastle Disease Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Newcastle Disease Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Newcastle Disease Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Newcastle Disease Vaccine by Type (2021-2026)
10.2 Newcastle Disease Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Newcastle Disease Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Newcastle Disease Vaccine by Application (2021-2026)
10.3 Newcastle Disease Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Newcastle Disease Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Newcastle Disease Vaccine by Region (2021-2026)
10.4 North America Newcastle Disease Vaccine Estimates and Projections (2021-2026)
10.5 Europe Newcastle Disease Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Newcastle Disease Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Newcastle Disease Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Newcastle Disease Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Sales (M Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Newcastle Disease Vaccine Sales (M Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Newcastle Disease Vaccine Market Size by Type (M Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Newcastle Disease Vaccine Manufacturers Covered in This Study
Table 5. Global Newcastle Disease Vaccine Sales (M Doses) by Manufacturers (2015-2020)
Table 6. Global Newcastle Disease Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Newcastle Disease Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Newcastle Disease Vaccine Sales Sites and Area Served
Table 11. Manufacturers Newcastle Disease Vaccine Product Types
Table 12. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newcastle Disease Vaccine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Newcastle Disease Vaccine Players
Table 16. Global Newcastle Disease Vaccine Sales (M Doses) by Region (2015-2020)
Table 17. Global Newcastle Disease Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Newcastle Disease Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Newcastle Disease Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Newcastle Disease Vaccine Sales by Country (2015-2020) (M Doses)
Table 21. North America Newcastle Disease Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Newcastle Disease Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Newcastle Disease Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Newcastle Disease Vaccine Sales by Country (2015-2020) (M Doses)
Table 25. Europe Newcastle Disease Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Newcastle Disease Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Newcastle Disease Vaccine Sales by Region (2015-2020) (M Doses)
Table 29. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Newcastle Disease Vaccine Sales by Country (2015-2020) (M Doses)
Table 33. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Newcastle Disease Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2015-2020) (M Doses)
Table 37. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2015-2020)
Table 41. Global Newcastle Disease Vaccine Sales Share by Type (2015-2020)
Table 42. Global Newcastle Disease Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Newcastle Disease Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2015-2020)
Table 45. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2015-2020)
Table 46. Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Newcastle Disease Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Merial Newcastle Disease Vaccine Corporation Information
Table 49. Merial Description and Business Overview
Table 50. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 51. Merial Main Product
Table 52. Merial Recent Development
Table 53. CEVA Newcastle Disease Vaccine Corporation Information
Table 54. CEVA Corporation Information
Table 55. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 56. CEVA Main Product
Table 57. CEVA Recent Development
Table 58. QYH Biotech Newcastle Disease Vaccine Corporation Information
Table 59. QYH Biotech Corporation Information
Table 60. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 61. QYH Biotech Main Product
Table 62. QYH Biotech Recent Development
Table 63. Ringpu Biology Newcastle Disease Vaccine Corporation Information
Table 64. Ringpu Biology Corporation Information
Table 65. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 66. Ringpu Biology Main Product
Table 67. Ringpu Biology Recent Development
Table 68. Yebio Newcastle Disease Vaccine Corporation Information
Table 69. Yebio Corporation Information
Table 70. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 71. Yebio Main Product
Table 72. Yebio Recent Development
Table 73. Harbin Veterinary Research Institute Newcastle Disease Vaccine Corporation Information
Table 74. Harbin Veterinary Research Institute Corporation Information
Table 75. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 76. Harbin Veterinary Research Institute Main Product
Table 77. Harbin Veterinary Research Institute Recent Development
Table 78. Merck Animal Health Newcastle Disease Vaccine Corporation Information
Table 79. Merck Animal Health Corporation Information
Table 80. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 81. Merck Animal Health Main Product
Table 82. Merck Animal Health Recent Development
Table 83. DHN Newcastle Disease Vaccine Corporation Information
Table 84. DHN Corporation Information
Table 85. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 86. DHN Main Product
Table 87. DHN Recent Development
Table 88. Zoetis Newcastle Disease Vaccine Corporation Information
Table 89. Zoetis Corporation Information
Table 90. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 91. Zoetis Main Product
Table 92. Zoetis Recent Development
Table 93. ChengDu Tecbond Newcastle Disease Vaccine Corporation Information
Table 94. ChengDu Tecbond Corporation Information
Table 95. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 96. ChengDu Tecbond Main Product
Table 97. ChengDu Tecbond Recent Development
Table 98. Elanco (Lohmann) Newcastle Disease Vaccine Corporation Information
Table 99. Elanco (Lohmann) Corporation Information
Table 100. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 101. Elanco (Lohmann) Main Product
Table 102. Elanco (Lohmann) Recent Development
Table 103. FATRO Newcastle Disease Vaccine Corporation Information
Table 104. FATRO Corporation Information
Table 105. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 106. FATRO Main Product
Table 107. FATRO Recent Development
Table 108. CAVAC Newcastle Disease Vaccine Corporation Information
Table 109. CAVAC Corporation Information
Table 110. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 111. CAVAC Main Product
Table 112. CAVAC Recent Development
Table 113. Vaksindo Newcastle Disease Vaccine Corporation Information
Table 114. Vaksindo Corporation Information
Table 115. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 116. Vaksindo Main Product
Table 117. Vaksindo Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Newcastle Disease Vaccine Distributors List
Table 121. Newcastle Disease Vaccine Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Newcastle Disease Vaccine Sales (M Doses) Forecast by Type (2021-2026)
Table 126. Global Newcastle Disease Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Newcastle Disease Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Newcastle Disease Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Newcastle Disease Vaccine Sales (M Doses) Forecast by Application (2021-2026)
Table 130. Global Newcastle Disease Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Newcastle Disease Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 132. Global Newcastle Disease Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Newcastle Disease Vaccine
Figure 2. Global Newcastle Disease Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Live Vaccines Product Picture
Figure 4. Killed Vaccines Product Picture
Figure 5. Global Newcastle Disease Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Chicken
Figure 7. Duck & Goose
Figure 8. Other
Figure 9. Global Newcastle Disease Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Newcastle Disease Vaccine Sales Capacity (M Doses) (2015-2026)
Figure 11. Global Newcastle Disease Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Newcastle Disease Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Newcastle Disease Vaccine Revenue in 2019
Figure 15. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Newcastle Disease Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Newcastle Disease Vaccine Sales Market Share by Region in 2019
Figure 18. Global Newcastle Disease Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Newcastle Disease Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Newcastle Disease Vaccine Sales Market Share by Country in 2019
Figure 21. North America Newcastle Disease Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 23. U.S. Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 25. Canada Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Newcastle Disease Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Newcastle Disease Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 29. Germany Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 31. France Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 33. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Italy Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 37. Russia Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Region in 2019
Figure 40. China Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 41. China Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Japan Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 45. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 47. India Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Australia Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 53. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 55. Thailand Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 57. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 59. Philippines Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 61. Vietnam Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Newcastle Disease Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Newcastle Disease Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 65. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 67. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 69. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 73. Turkey Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 75. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Newcastle Disease Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 77. U.A.E Newcastle Disease Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Newcastle Disease Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Newcastle Disease Vaccine by Type in 2019
Figure 80. Revenue Share of Newcastle Disease Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Newcastle Disease Vaccine by Type in 2019
Figure 82. Global Newcastle Disease Vaccine Sales Growth by Type (2015-2020) (M Doses)
Figure 83. Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Newcastle Disease Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Newcastle Disease Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Newcastle Disease Vaccine by Application in 2020
Figure 87. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. CEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. QYH Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ringpu Biology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Yebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Harbin Veterinary Research Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. DHN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. ChengDu Tecbond Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Elanco (Lohmann) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. FATRO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Vaksindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Newcastle Disease Vaccine
Figure 103. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 104. Newcastle Disease Vaccine Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 109. North America Newcastle Disease Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Newcastle Disease Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Newcastle Disease Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Newcastle Disease Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Newcastle Disease Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Newcastle Disease Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed
  • Global Newcastle Disease Vaccine Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 117
    Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens. The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to ......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 137
    Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. The classification of Foot and Mouth Disease Vaccines includes Emergency Vaccines and Conventional Vaccines, and the proportion of Conventional Vaccines in 2016 is about 70%, and the proportion is decreasing t......
  • Global Tylosin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 102
    Summary Market Overview The global Tylosin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 762.5 million by 2025, from USD 651.3 million in 2019. The Tylosin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis......
  • Global Classical Swine Fever Vaccines Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 117
    Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is abou......
  • Global Porcine Serum Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
    Published: 31-Dec-2019        Price: US 3350 Onwards        Pages: 129
    Summary The global Porcine Serum market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025. This report studies the Porcine Serum market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, ri......
  • Global Animal Antibiotics Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
    Published: 31-Dec-2019        Price: US 3350 Onwards        Pages: 114
    Summary The global Animal Antibiotics market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025. This report studies the Animal Antibiotics market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and chal......
  • Global Animal Parasiticides Market Data Survey Report 2015-2025
    Published: 30-Dec-2019        Price: US 1500 Onwards        Pages: 78
    Summary The global Animal Parasiticides market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile......
  • Global Animal Wound Care Market Data Survey Report 2015-2025
    Published: 30-Dec-2019        Price: US 1500 Onwards        Pages: 79
    Summary The global Animal Wound Care market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, s......
  • Global Animal Parasiticide Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 30-Dec-2019        Price: US 2600 Onwards        Pages: 194
    In this report, we analyze the Animal Parasiticide industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs